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Early-onset haemochromatosis caused by a novel
combination of TFR2 mutations(p.R396X/c.1538-
2 A>G) in a woman of Italian descent
Haemochromatosis (HC) refers to a group of inherited
disorders of iron metabolism characterized by progres-
sive iron accumulation in parenchymal cells. If not recog-
nized and treated, iron loading impairs the function of
target organs and damages their structure. HC includes
the historical and predominant HFE-related condition,
and rarer conditions which have more recently been
associated with mutations in the hemojuvelin (HJV),
hepcidin (HAMP) and transferrin receptor 2 (TFR2)
genes. HC also involves certain mutations of the ferro-
portin gene (SLC40A1), albeit most of the SLC40A1-
related patients display a distinct iron overload syn-
drome that is recognized as the ferroportin disease.1
In the present study, we aimed to identify the genetic
basis of iron overload in a 28-year-old woman of Italian
descent. The patient was referred to us, in the context of
a premarital medical evaluation, because of high levels of
serum iron (381 µg/dL; Normal range: 50-160), transfer-
rin saturation (determined twice: at 80 and 93%, respec-
tively) and serum ferritin (900 µg/L; N: 10-291). She did
not present clinical manifestations of HC, except of
astheny. Secondary causes of iron overload were exclud-
ed. The patient denied any history of alcohol abuse or
blood transfusion, serologies for hepatitis A and C were
negative, vaccination against hepatitis B had been per-
formed, and hematological constants were in the normal
range (hemoglobin: 13 g/dL, white blood cells: 7.15
109/L, platelets: 355x109/L). In addition, the patient had
normal levels of liver enzymes (ASAT, ALAT, γ-GT) and
normal blood sugar parameters, while moderate increas-
es in C reactive protein concentration (8 mg/L, N<5) and
Erythrocyte Sedimentation Rate (36, N<15) were
observed. Because of the clearly elevated serum ferritin
concentration, the hepatic iron overload was investigat-
ed by magnetic resonance imaging (MRI). It was estimat-
ed to be quite high (with a Hepatic Iron Content of
310±50 µg/L, N <36; the calculation being performed
with the algorithm developed by Gandon Y. and collab-
orators,2 for a magnetic field of 1.5 Tesla). Imaging fur-
ther showed that iron deposits were homogeneously dis-
tributed. No liver biopsy was performed. At present, the
patient is included in a phlebotomy program. Although
2.3g of iron had been removed, both the serum ferritin
concentration (279 µg/L) and the transferrin saturation
level (53%) remain elevated. Of note, the C reactive pro-
tein concentration had been normalized (1 mg/L).
After obtaining written informed consent, we
searched for the p.C282Y, p.H63D and p.S65C HFE vari-
ations. As this specific screening was negative, we
scanned the entire coding regions and splicing junctions
of the five haemochromatosis genes. This allowed us to
only detect two mutations in the TFR2 gene (Genbank #
NM_003227.3): a heterozygous C>T transition at
nucleotide c.1186 in exon 9 (Figure 1A), and a heterozy-
gous A>G transition at nucleotide c.1538-2, in intron 12
(Figure 1B). The c.1186 C>T substitution results in a pre-
mature stop codon at amino-acid 396 (p.R396X). This
mutation is not new, since it has been previously report-
ed in an haemochromatosis patient of Scottish descent.3
The novel c.1538-2 A>G substitution abrogates the
intron 12 acceptor splicing site as it changes the critical
AG sequence into GG. This splicing mutation is expect-
ed to dramatically modify the TFR2 reading frame,
which encompasses 18 exons and ends with nucleotide
triplets encodings the TFR2 dimerization domain. This
was not experimentally verified because of the paucity of
TFR2 mRNA in circulating blood cells.
It is well recognized that iron overload phenotypes
observed in HC are highly variable. Taking into account
the influence of environmental factors and of potential
modifier genes, one may consider that these phenotypes
actually constitute a continuum. Nevertheless, different
grades of severity can be attributed to the genetic hetero-
geneity of the disease, in particular when considering the
respective roles of HC proteins in iron homeostasis.
These grades range from the HJV and HAMP-related
juvenile conditions to the typical adult-onset HFE-relat-
ed condition, which is usually diagnosed in the fourth
decade for men and the fifth for women. The iron over-
load course in TFR2-related patients is distinct from that
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Figure 1. Sequencing electrophoregrams showing the mutated
TFR2 exon 9 (A) and intron 12 (B) forward heterozygous
sequences (position of the c.1186 A>G and c.1538-2 A>G
nucleotide change are indicated by arrows and the intron 12/exon
13 junction is delimited by dashes).
 
of the juvenile conditions, but it can be more rapid and
impressive than usually observed in HFE-related
patients. Indeed, based on the review of the 23 TFR2-
related cases reported in the literature until 2004 and
with considering a cohort of 421 HFE p.C282Y/p.C282Y
homozygous patients, we previously showed that age at
diagnosis in TFR2-related patients was significantly
lower than in HFE-related patients. We also highlighted
the descriptions of clinical features (including arthralgy,
hypogonadism, skin pigmentation and cirrhosis) in
TFR2-related patients before the age of 30 years.4 Our
observations have been reinforced by some recent
reports, in which the identification of TFR2 mutations
was correlated with the description of either high serum
iron parameters in young patients or severe clinical pic-
tures in older patients.3,5-9 In a retrospective analysis of 33
cautiously selected Italian cases, Biasiotto and co-work-
ers have more especially identified two children with
new TFR2 causative mutations.9 The authors argued for
a TFR2 genotyping in patients with early-onset of iron
overload, and they further stressed that the TFR2-related
HC is characterized by high transferrin saturation levels.
Furthermore, mice homozygous for the p.Y245X TFR2
mutation (the murine ortholog of the human p.Y250X
mutation 5 identified in the first TFR2-related pedigrees
of HC) have proved to develop a more rapid hepatic iron
overload than HFE knock-out mice of the same genetic
background.10
In conclusion, it becomes more and more evident that
TFR2-related HC is an intermediate syndrome between
the typical adult-onset HFE-related HC and the two juve-
nile conditions. Thus, the search for TFR2 mutations
should be particularly considered in young patients with
haemochromatosis which do not exhibit a juvenile con-
dition.
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